MAPT and Alzheimer disease: For instance, in AD mouse models, D + Q reduced the burden of amyloid-beta plaques and hyperphosphorylated tau aggregates, potentially by restoring proteostasis mechanisms and reducing the inflammatory milieu that exacerbates protein misfolding [109].